Modified drug regimen for ophthalmic anesthesia during COVID-19 pandemic: Revisiting pharmacological concepts.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 178, doi. 10.4103/ijp.ijp_89_21
- By:
- Publication type:
- Article
Works matching IS 02537613 AND DT 2021 AND VI 53 AND IP 2
Results: 16
1
2
Antimicrobial prescribing in dental practice during COVID 19: Its impact on antimicrobial resistance.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 180, doi. 10.4103/ijp.ijp_303_21
- By:
- Publication type:
- Article
3
Randomized trial of vilazodone versus sertraline in depression: Concerns and comments.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 176, doi. 10.4103/ijp.IJP_288_20
- By:
- Publication type:
- Article
4
Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 174, doi. 10.4103/ijp.IJP_785_19
- By:
- Publication type:
- Article
5
Unmet needs of corneal collagen cross-linking.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 173, doi. 10.4103/ijp.IJP_450_19
- By:
- Publication type:
- Article
6
Fixed-dose combinations: An essential for rational preparation.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 170, doi. 10.4103/ijp.IJP_133_19
- By:
- Publication type:
- Article
7
Current status of in silico, preclinical and clinical study registries across the globe: A systematic review and meta-analysis.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 160, doi. 10.4103/ijp.ijp_1090_20
- By:
- Publication type:
- Article
8
Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
9
Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
10
Adverse event reporting tools and regulatory measures in India through outcome of pharmacovigilance programme of India.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 143, doi. 10.4103/ijp.ijp_901_20
- By:
- Publication type:
- Article
11
Therapeutic potential of diosmin, a citrus flavonoid against arsenic-induced neurotoxicity via suppression of NOX 4 and its subunits.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 132, doi. 10.4103/ijp.IJP_837_19
- By:
- Publication type:
- Article
12
Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 125, doi. 10.4103/ijp.IJP_506_19
- By:
- Publication type:
- Article
13
Questionnaire-based Pan-India survey for impact assessment of National Formulary of India.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 115, doi. 10.4103/ijp.ijp_353_21
- By:
- Publication type:
- Article
14
Prediction of pharmacokinetic values of two various dosages of caffeine in premature neonates with apnea.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 108, doi. 10.4103/ijp.IJP_504_19
- By:
- Publication type:
- Article
15
Medication - A boon or bane: Emergencies due to medication-related visits.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 103, doi. 10.4103/ijp.IJP_357_20
- By:
- Publication type:
- Article
16
Marathon mice: Researcher view on potential roles in preclinical research.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 99, doi. 10.4103/ijp.ijp_324_21
- By:
- Publication type:
- Article